These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12141520)

  • 1. The surfactants.
    Kallapur S; Ikegami M
    Am J Perinatol; 2000; 17(7):335-43. PubMed ID: 12141520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
    Notter RH; Shapiro DL
    Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM; Bae CW; Oh MH; Lee SH; Woo KM; Jung KB
    J Perinat Med; 2009; 37(5):561-4. PubMed ID: 19492923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of respiratory distress syndrome in premature infants with pulmonary surfactant].
    Gortner L
    Klin Padiatr; 1989; 201(6):417-24. PubMed ID: 2689769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS.
    Golombek SG; Truog WE
    J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questions about surfactant for respiratory distress syndrome (RDS).
    Jobe A
    Mead Johnson Symp Perinat Dev Med; 1987; (30):43-51. PubMed ID: 3333418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.